Cargando…

N-Acetylcysteine causes analgesia in a mouse model of painful diabetic neuropathy

N-Acetylcysteine, one of the most prescribed antioxidant drugs, enhances pain threshold in rodents and humans by activating mGlu2 metabotropic glutamate receptors. Here, we assessed the analgesic activity of N-acetylcysteine in the streptozotocin model of painful diabetic neuropathy and examined the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Notartomaso, Serena, Scarselli, Pamela, Mascio, Giada, Liberatore, Francesca, Mazzon, Emanuela, Mammana, Santa, Gugliandolo, Agnese, Cruccu, Giorgio, Bruno, Valeria, Nicoletti, Ferdinando, Battaglia, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997966/ https://www.ncbi.nlm.nih.gov/pubmed/32009537 http://dx.doi.org/10.1177/1744806920904292

Ejemplares similares

Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
por: Notartomaso, Serena, et al.
Publicado: (2017)

Perineuronal nets are under the control of type-5 metabotropic glutamate receptors in the developing somatosensory cortex
por: Mascio, Giada, et al.
Publicado: (2021)

mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
por: Notartomaso, Serena, et al.
Publicado: (2018)

Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic Pain
por: Notartomaso, Serena, et al.
Publicado: (2022)

Targeting mGlu1 Receptors in the Treatment of Motor and Cognitive Dysfunctions in Mice Modeling Type 1 Spinocerebellar Ataxia
por: Liberatore, Francesca, et al.
Publicado: (2022)

Light-Induced Activation of a Specific Type-5 Metabotropic Glutamate Receptor Antagonist in the Ventrobasal Thalamus Causes Analgesia in a Mouse Model of Breakthrough Cancer Pain
por: Notartomaso, Serena, et al.
Publicado: (2022)

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
por: Mammana, Santa, et al.
Publicado: (2019)

The neuropathic pain: An overview of the current treatment and future therapeutic approaches
por: Cavalli, Eugenio, et al.
Publicado: (2019)

N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans
por: Truini, Andrea, et al.
Publicado: (2015)

Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
por: Notartomaso, Serena, et al.
Publicado: (2013)

N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors
por: Bernabucci, Matteo, et al.
Publicado: (2012)

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia
por: Nicoletti, Ferdinando, et al.
Publicado: (2019)

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018)

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2019)

MiR-155: An Important Regulator of Neuroinflammation
por: Zingale, Valeria Domenica, et al.
Publicado: (2021)

Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury
por: Mammana, Santa, et al.
Publicado: (2019)

Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration
por: Gugliandolo, Agnese, et al.
Publicado: (2021)

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
por: Mangano, Katia, et al.
Publicado: (2018)

Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy
por: Lombardo, Salvo Danilo, et al.
Publicado: (2019)

α-Tocopherol Modulates Non-Amyloidogenic Pathway and Autophagy in an In Vitro Model of Alzheimer’s Disease: A Transcriptional Study
por: Gugliandolo, Agnese, et al.
Publicado: (2019)

MiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target
por: Gugliandolo, Agnese, et al.
Publicado: (2021)

Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models
por: Gugliandolo, Agnese, et al.
Publicado: (2017)

Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
por: Gugliandolo, Agnese, et al.
Publicado: (2019)

Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients
por: Chiricosta, Luigi, et al.
Publicado: (2021)

Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties
por: Schepici, Giovanni, et al.
Publicado: (2022)

Serum-Free Cultures: Could They Be a Future Direction to Improve Neuronal Differentiation of Mesenchymal Stromal Cells?
por: Schepici, Giovanni, et al.
Publicado: (2022)

Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
por: Tardiolo, Giuseppe, et al.
Publicado: (2018)

Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
por: Fagone, Paolo, et al.
Publicado: (2019)

Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Moringin from Moringa Oleifera Seeds Inhibits Growth, Arrests Cell-Cycle, and Induces Apoptosis of SH-SY5Y Human Neuroblastoma Cells through the Modulation of NF-κB and Apoptotic Related Factors
por: Cirmi, Santa, et al.
Publicado: (2019)

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis
por: Mammana, Santa, et al.
Publicado: (2018)

The Transcriptomic Analysis of NSC-34 Motor Neuron-Like Cells Reveals That Cannabigerol Influences Synaptic Pathways: A Comparative Study with Cannabidiol
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Differential modulation and prognostic values of immune-escape genes in uveal melanoma
por: Basile, Maria Sofia, et al.
Publicado: (2019)

Could the Heat Shock Proteins 70 Family Members Exacerbate the Immune Response in Multiple Sclerosis? An in Silico Study
por: Chiricosta, Luigi, et al.
Publicado: (2020)

Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
por: Blando, Santino, et al.
Publicado: (2022)

Cannabinerol and NSC-34 Transcriptomic Analysis: Is the Dose Who Makes Neuronal Differentiation?
por: Valeri, Andrea, et al.
Publicado: (2022)

In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2020)

Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nijvqcaq6n4aiqa0j4vcfe7pbp